Skip to main content
Clinical Trials/CTRI/2021/09/036397
CTRI/2021/09/036397
Not Yet Recruiting
N/A

A prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Prof Dr med Thorsten Khn0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: C506- Malignant neoplasm of axillary tail of breast
Sponsor
Prof Dr med Thorsten Khn
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Prof Dr med Thorsten Khn

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent form
  • \- Primary invasive breast cancer (confirmed by core biopsy)
  • \- cN\+ (confirmed by core biopsy/fine needle aspiration or presence of highly suspicious axillary node\[s] on imaging)
  • \- In case a minimally invasive biopsy of axillary lymph node(s) has been performed and yielded a negative or inconclusive result, patients may be included if the final classification after imaging\-pathology\-correlation is cN\+
  • \- cT1\-cT4c
  • \- Scheduled for neoadjuvant systemic therapy
  • \- Female / male patients \>\= 18 years old

Exclusion Criteria

  • Distant metastasis
  • \- Recurrent breast cancer
  • \- Inflammatory breast cancer
  • \- Extramammary breast cancer
  • \- Bilateral breast cancer
  • \- History of invasive breast cancer, DCIS or any other invasive cancer
  • \- Confirmed or suspected supraclavicular lymph node metastasis
  • \- Confirmed or suspected parasternal lymph node metastasis
  • \- Axillary surgery before NACT (e.g. SLNB or nodal sampling)
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials